靶向 CD33/CD123 的双特异性 CAR-T 细胞用于治疗急性髓系白血病
Bispecific CD33/CD123 targeted chimeric antigen receptor T cells for the treatment of acute myeloid leukemia.
肿瘤细胞治疗研究
FRONTIER PAPERS
近 5 年肿瘤细胞治疗领域的研究论文。默认按评分排序(权威性 + 新鲜度)。
Bispecific CD33/CD123 targeted chimeric antigen receptor T cells for the treatment of acute myeloid leukemia.
Challenges and Advances in Chimeric Antigen Receptor Therapy for Acute Myeloid Leukemia.
共 2 条
MEMBER ACCOUNT
登录成功会直接打开下一页。